Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 apiece, ...
WORTHINGTON, Ohio, October 14, 2025--(BUSINESS WIRE)--I Am Boundless, Inc., a nonprofit leader in integrated care for individuals with intellectual and developmental disabilities (I/DD) and behavioral ...
Boundless Bio’s announcement earlier this month of plans to go public was a sign that the biotech IPO window hadn’t slammed shut after a flurry of offerings at the start of the year. Now, the company ...
New platform connects high capacity leaders navigating high stakes inflection points with rigorously vetted human ...
I Am Boundless, Inc. launched its #BoundlesslyBeautiful campaign to promote inclusivity and to challenge societal beauty standards. The event aimed to empower the women, to give them a voice and ...
Targeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...
ORLANDO, Fla., September 24, 2025--(BUSINESS WIRE)--Boundless Learning, a leading education solutions provider, is excited to announce its strategic partnership with the Higher Education Systems & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results